Product
EBV-specific TCR-T cell with anti-PD1 auto-secreted element
1 clinical trial
1 indication
Indication
Head and Neck Squamous Cell CarcinomaClinical trial
Single-Arm Trial of EBV-Specific TCR-T Cells With Anti-PD1 Auto-secreted Element in the Treatment of EBV-Positive Head and Neck CarcinomaStatus: Recruiting, Estimated PCD: 2024-01-01